Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Opiate Dependency Relapse”

11 trials

Showing 11 of 11 results

Post-approval studies (Phase 4)Study completedNCT00763958
What this trial is testing

Relapse Prevention to Reduce HIV Among Women Prisoners

Who this might be right for
Opioid DependenceHIV
University of Alabama at Birmingham 44
Large-scale testing (Phase 3)Study completedNCT02696096
What this trial is testing

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

Who this might be right for
Opioid Addiction
Butler Hospital 21
Not applicableStudy completedNCT00292136
What this trial is testing

Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study

Who this might be right for
Cocaine AddictionOpiate Addiction
National Institute on Drug Abuse (NIDA) 230
Not applicableUnknownNCT01274988
What this trial is testing

Deep Brain Stimulation of Nucleus Accumbens to Prevent Opiate Relapse

Who this might be right for
Addiction
Tang-Du Hospital 20
Not applicableStudy completedNCT01955902
What this trial is testing

Using mHealth to Aid Opioid Addicts

Who this might be right for
Opiate Dependency Relapse
Care Team Solutions 11
Testing effectiveness (Phase 2)Study completedNCT01587196
What this trial is testing

CURE Addiction Center of Excellence: Brain Mechanisms of Relapse and Recovery

Who this might be right for
Prescription Opiate/Medication Dependence
University of Pennsylvania 72
Not applicableUnknownNCT03424616
What this trial is testing

Deep Brain Stimulation of Nucleus Accumbens for Opioid Relapse Prevention

Who this might be right for
Addiction
Tang-Du Hospital 60
Testing effectiveness (Phase 2)Study completedNCT00142909
What this trial is testing

Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1

Who this might be right for
Opioid-Related Disorders
Yale University 86
Large-scale testing (Phase 3)Study completedNCT01180647
What this trial is testing

Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail

Who this might be right for
Opiate Dependence
NYU Langone Health 48
Large-scale testing (Phase 3)Study completedNCT00521157
What this trial is testing

Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction

Who this might be right for
Opiate Dependence
University of Oslo 56
Large-scale testing (Phase 3)Study completedNCT01882361
What this trial is testing

Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone

Who this might be right for
Opiate DependenceHuman Immunodeficiency Virus
University of Pennsylvania 77

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation